A Search Service for Abbreviation / Long Form

â–  Abbreviation / Long Form : ANCA / antineutrophil cytoplasmic antibody

[Related PubMed/MEDLINE]
Total Number of Papers: 2890
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ANCA  (>> Co-occurring Abbreviation)
Long Form:   antineutrophil cytoplasmic antibody
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A "double-seropositive" Vasculitis for antiglomerular basement membrane antibodies and antineutrophil cytoplasmic antibody, and multiple myeloma, all three with simultaneous diagnosis of renal involvement, common pathophysiology, or pure coincidence? first case in the World. GBM, IgG, MM
2019 A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. AAV, MPO, NETs, PTU, PTU-AAV
2019 A Case Report of Multiple Myeloma Associated With Myeloperoxidase and Proteinase-3 Antibodies Posing a Diagnostic Dilemma. MM, MPO, PR3
2019 A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation. MPO, NE, NETs, SLE
2019 A Pediatric Case of a D-Penicillamine Induced ANCA-associated Vasculitis Manifesting a Pulmonary-Renal Syndrome. ---
2019 A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity. AAV, MPO
2019 A relapsing case of pulmonary-renal syndrome after a sequential rise in MPO-ANCA and anti-GBM antibodies. Ab, GBM, MPO, PRS
2019 A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis. ---
2019 Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management. GCA, GPA, TAK
10  2019 Analysis of the B cell receptor repertoire in six immune-mediated diseases. BCR, IgA, IGHV
11  2019 ANCA associated vasculitis: experience of a tertiary care referral center. ---
12  2019 ANCA positivity at the time of renal biopsy is associated with chronicity index of lupus nephritis. LN, PR3
13  2019 Anca-associated crescentic glomerulonephritis in a child with isolated renal involvement. CYC, GN
14  2019 ANCA-Associated Vasculitis: Core Curriculum 2020. ---
15  2019 Anemia Combined Significantly Increased High-Sensitivity C Reactive Protein and Lung Lesions Lead to the Diagnosis of Granulomatosis with Polyangiitis Proven by Lung Biopsy and Anti-neutrophil Cytoplasmic Antibody Test. PR3
16  2019 Anti-Neutrophil Cytoplasmic Antibodies Positivity and Anti-Leukotrienes in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Monocentric Study on 134 Italian Patients. EGPA, LTRAs
17  2019 Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis Causes Aortic Valve Degeneration and Severe Aortic Regurgitation. CSS, EGPA, GPA, WG
18  2019 Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer. GPA
19  2019 Anti-proteinase 3-positive Eosinophilic Granulomatosis with Polyangiitis Revealed by Cardiac Tamponade: A Case Report. anti-PR3, EGPA
20  2019 Antineutrophil cytoplasmic antibody and/or antiglomerular basement membrane antibody associated crescentic glomerulonephritis in combination with IgG4-related tubulointerstitial nephritis. anti-GBM, IgG4, IgG4-RKD, IgG4-TIN
21  2019 Antineutrophilic cytoplasmic antibody-associated vasculitis with and without renal involvement: C3 contributes to prognosis, but renal involvement does not. ---
22  2019 Aortitis caused by antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a case-based review. ---
23  2019 Association of PTPN22 1858C/T Polymorphism with Autoimmune Diseases: A Systematic Review and Bayesian Approach. GWAS, PTPN22
24  2019 Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. AAV, HRs, PR3, VTE
25  2019 Azathioprine Hypersensitivity Syndrome in a Cohort of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients. CRP, IQR, TPMT
26  2019 Celiac disease-specific and inflammatory bowel disease-related antibodies in patients with recurrent aphthous stomatitis. anti-tTG, CeD, DGP, IBD, IIF, RAS
27  2019 Characteristics and Outcomes of Patients with Anti-Glomerular Basement Membrane Antibody Disease and Anti-Neutrophil Cytoplasmic Antibodies. DP, GBM
28  2019 Chemokine Receptor 8 Can Distinguish Antineutrophil Cytoplasmic Antibody-Associated Vasculitis From Infectious Complications. CCR8
29  2019 Chest High-Resolution CT Findings of Microscopic Polyangiitis: A Japanese First Nationwide Prospective Cohort Study. HRCT, IP, MPA, MPO, UIP
30  2019 Cladophialophora bantiana infection mimicking neuromyelitis optica. C. bantiana, Gd, NMO
31  2019 Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis. ESRD, FFS, MPO, PR3
32  2019 Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study. MPO, PR3
33  2019 Clinical characteristics of Polish patients with ANCA-associated vasculitides-retrospective analysis of POLVAS registry. CI, POLVAS, pRRT
34  2019 Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis). RA
35  2019 Clinical Effect of Alpha-1 Antitrypsin Deficiency in Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Results from a French Retrospective Monocentric Cohort. AAT, AAV, GPA, IAH, MPA
36  2019 Clinical implication of chronic paranasal sinusitis for the classification of microscopic polyangiitis. CPS, GPA, MPA
37  2019 Clinical significance of ANCA positivity in patients with IgA vasculitis: a retrospective monocentric study. AAV, CKD, ESRD, ISKDC, MPO
38  2019 Clinical significance of autoantibody positivity in idiopathic pulmonary fibrosis. IPAF, IPF
39  2019 Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis. cANCA, ELISA, MPO, PR3
40  2019 Clinicopathological analysis of ANCA-associated glomerulonephritis focusing on plasma cell infiltrate. ANCA-GN, IgG4-RD
41  2019 Co-occurrence of PLA2R-positive membranous nephropathy without crescents, and PR3-positive eosinophilic granulomatosis with polyangiitis
. EGPA, PLA2R, PMN, PR3
42  2019 Cocaine-induced ANCA-associated renal disease: a case-based review. ---
43  2019 Comparing outcomes of biopsy-proven anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis patients treated with cyclophosphamide in the 20th and 21st centuries: a 23-year study. ---
44  2019 Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature. GPA, IgG4-RD
45  2019 Cost-effectiveness of rituximab versus azathioprine for maintenance treatment in antineutrophil cytoplasmic antibody-associated vasculitis. ICER, ICUR, QALY
46  2019 Detection of Anti-neutrophil Cytoplasmic Antibodies (ANCA) by Indirect Immunofluorescence. IIF
47  2019 Determination of Subset-Restricted Anti-neutrophil Cytoplasmic Antibodies (ANCA) by Immunofluorescence Cytochemistry. ANCAs, IIF, OLFM4
48  2019 Differences in clinico-pathological characteristics and outcomes between proteinase 3-ANCA positivity and myeloperoxidase-ANCA positivity in lupus nephritis. ANA, LN, MPO, PR3
49  2019 Differentiation Between Eosinophilic Otitis Media and Otitis Media Associated With Eosinophilic Granulomatosis With Polyangiitis. EGPA, EGPA, EOM, EOM, Ig
50  2019 Diffuse alveolar hemorrhage in a patient with ANCA-associated vasculitis after thyroidectomy: A case report. DAH
51  2019 Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. CVD, PR3, RAVE
52  2019 Do ANCA-associated vasculitides and IgG4-related disease really overlap or not? IgG4-RD
53  2019 Dual anti-neutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody-positive crescent glomerulonephritis in a patient with monoclonal gammopathy of undetermined significance: A case report. GBM, MGUS, MIg, MPO, PCD
54  2019 Dynamics of D-serine reflected the recovery course of a patient with rapidly progressive glomerulonephritis. AKI, FE, GFR, RPGN, SLE
55  2019 Early development of new cardiovascular risk factors in the systemic vasculitides. AAV, CV, DCVAS, GCA, HTN/DM
56  2019 Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. ESRF, HR
57  2019 Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study. BVAS, HR, MPO, PR3, PSE
58  2019 Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis. BVAS, EGPA, ENT
59  2019 Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis. MAAV, ScFv
60  2019 Eosinophilic granulomatosis with polyangiitis in a Nigerian woman. EGPA
61  2019 Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients. EGPA
62  2019 Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis. EGPA, ESRD, GPA, MPA
63  2019 Estimating the Change in Renal Function During the First Year of Therapy in ANCA-Associated Vasculitis. ANOVAs, ATI, GFR
64  2019 Etiology and outcome of pulmonary renal syndrome: Retrospective study from a tertiary care hospitaln. AAV, GPA, PRS
65  2019 Evaluation of 12 different assays for detecting ANCA in Chinese patients with GPA and MPA: a multicenter study in China. AAV, CLIA, ELISA, GPA, IIF, LIA, MPA, MPO, PR3
66  2019 Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis. AAV, PR3
67  2019 Exclusively ocular and cardiac manifestation of granulomatosis with polyangiitis - a case report. GPA
68  2019 Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. NETs
69  2019 Gene Expression Pathways across Multiple Tissues in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Reveal Core Pathways of Disease Pathology. md-locfdr
70  2019 Genetic Variants in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Bayesian Approach and Systematic Review. BFDP, CI, EMBASE, FPRP, GO, GWASs, IFN-gamma, MHC, OR, PPI, SNPs
71  2019 Granulomatosis with polyangiitis in a patient with biopsy-proven IgG4-related pulmonary disease and coincident small cell lung cancer. GPA, IgG4-RD
72  2019 Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist. AAV, EGPA, GPA, MPA
73  2019 High serum hepcidin is associated with the occurrence of anemia in anti-myeloperoxidase antibody-associated vasculitis with normal kidney function: a cross-sectional study. MPO
74  2019 Histopathological classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a nationwide Japanese prospective 2-year follow-up cohort study. eGFR
75  2019 Humanised effector-null FcgammaRIIA antibody inhibits immune complex-mediated proinflammatory responses. Ab, GLP, ICs, PK
76  2019 Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients. AAV, GPA, HPM, MRI
77  2019 IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis. AAV
78  2019 Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity. AAV, MPO, PR3
79  2019 Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort. AAV, CI, CS, MPA, MPO
80  2019 Increased formation of neutrophil extracellular traps is associated with gut leakage in patients with type 1 but not type 2 diabetes. C5a, LPS, NE, NETs, PAD4, PR3, T2D
81  2019 Individualised Homeopathic Therapy in ANCA Negative Rapidly Progressive Necrotising Crescentic Glomerulonephritis with Severe Renal Insufficiency - A Case Report. RPGN
82  2019 Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review. IL, RA, SLE
83  2019 Is granulomatosis with polyangiitis in Asia different from the West? AAV, GPA, MPA, MPO, PR3
84  2019 Isolated choroid plexus involvement in a case of granulomatosis with polyangiitis negative for antineutrophil cytoplasmic antibodies (ANCA). ---
85  2019 Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis. BVAS, CI, ESRD, EUVAS, HR
86  2019 Low serum complement 3 level is associated with severe ANCA-associated vasculitis at diagnosis. BVAS, OR, RR
87  2019 Macrophage migration inhibitory factor is involved in antineutrophil cytoplasmic antibody-mediated activation of C5a-primed neutrophils. MIF, MPO, mPR3
88  2019 Manifest interstitial and vascular pathology in anti-neutrophil cytoplasmic antibody-associated renal disease. ---
89  2019 Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis. EGPA, IL-5
90  2019 Microscopic polyangiitis associated with subarachnoid hemorrhage. MPA, SAH
91  2019 Microscopic polyangiitis in a case of silica exposure: a rare presentation. DAH
92  2019 Multiple cutaneous and mucosal lesions in a patient with cocaine-levamisole-induced vasculopathy syndrome. ---
93  2019 Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial. MMF
94  2019 Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China. AAV, GPA, MPA, MPO, PR3
95  2019 Neurological Manifestations Do not Affect Cumulative Survival in Indian Patients with Antineutrophil Cytoplasmic Antibody Associated Vasculitis. AAV, BVAS, CSS, GPA, IQR
96  2019 Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation. GPA, HC, MP, MPA
97  2019 New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group. EGPA, HESs
98  2019 No Difference in Cognitive Dysfunction Among Patients with ANCA-Associated Vasculitis, Rheumatoid Arthritis or Chronic Kidney Disease. CD, CKD, HADS, NEUROPSI, RA
99  2019 Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited. PK-PD
100  2019 Occurrence of cerebral small vessel disease at diagnosis of MPO-ANCA-associated vasculitis. MPO, MRI, SVD